<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Anderson EMS Pocket Medic</title>
    <link rel="icon" href="../favicon.ico" type="image/png" />
    <link rel="stylesheet" href="../AdultMedical.css" />
    <link rel="stylesheet" href="Asthmas.css" />
  </head>
  <body>
    <a href="../../../index.html" class="header-link">
      <div class="header">
        <h1>Anderson EMS Pocket Medic</h1>
      </div>
    </a>

    <div class="MainBody">
      <h2>
        Bronchospasm <br />
        Asthma <br />
        COPD
      </h2>

      <div class="InitialBody">
        <table class="StartTable">
          <thead>
            <tr>
              <th>History</th>
              <th>Signs and Symptoms</th>
              <th>Differential</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>
                • Asthma, COPD, Chronic Bronchitis, Emphysema history<br /><br />
                • Onset of symptoms<br /><br />
                • Concurrent symptoms (fever, cough, rhinorrhea, tongue/lip
                swelling, rash, labored breathing, FBAO)<br /><br />
                • Usual triggers of symptoms (cigarette smoke, change in
                weather, URI)<br /><br />
                • Home treatment (oxygen, nebulizers)<br /><br />
                • Sick contacts<br /><br />
                • Previously intubated
              </td>
              <td>
                • Shortness of breath (inability to speak full sentences)<br /><br />
                • Wheezing, rhonchi<br /><br />
                • Fever, cough, congestion<br /><br />
                • Respiratory distress (hypoxia, retractions, nasal flaring,
                pursed lip breathing, tripoding, cyanosis, tachypnea, etc)
              </td>
              <td>
                • Asthma<br /><br />
                • Anaphylaxis<br /><br />
                • Aspiration<br /><br />
                • COPD<br /><br />
                • Pleural effusion<br /><br />
                • Pneumonia<br /><br />
                • Pulmonary embolus<br /><br />
                • Pneumothorax<br /><br />
                • Cardiac (MI or CHF)<br /><br />
                • Pericardial tamponade<br /><br />
                • Hyperventilation<br /><br />
                • Inhaled toxin
              </td>
            </tr>
          </tbody>
        </table>

        <h3 class="AllLevels">EMR</h3>
        <p>
          1.
          <a
            href="../../General/UniversalSources/Universal.html"
            class="working-link"
            title="Universal Patient care SOG"
            >UNIVERSAL PATIENT CARE</a
          >.<br /><br />

          2.<a
            href="../../../DrugMaterial/AlbuterolFolder/albuterol.html"
            class="working-link"
            title="Albuterol Med Page"
            >ALBUTEROL</a
          >
          <strong>(5 mg)</strong> or
          <a
            href="../../../DrugMaterial/DuoNebFolder/duoneb.html"
            class="working-link"
            title="DuoNeb Med Page"
            >Pre-mix IPRATROPIUM BROMIDE/ALBUTEROL</a
          >
          <strong>(0.5 mg/3 mg</strong>) via nebulizer. May repeat x2 if needed
          for continued symptomatic relief.<br /><br />

          3. Relay information to incoming ambulance or call for intercept per
          <a
            href="../../General/InterceptCriteriaSources/Intercept.html"
            class="working-link"
            title="Intercept Criteria SOG"
            >INTERCEPT CRITERIA</a
          >.
        </p>
        <h3 class="EMT">EMT</h3>
        <p>
          1. Continue <strong>EMR TREATMENT</strong>. <br /><br />

          2. Consider
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a>
          application <br /><br />

          3. If in <u>severe</u> distress with impending respiratory failure,
          consider
          <a
            href="../../../DrugMaterial/Epi1000Folder/epi1000.html"
            class="working-link"
            title="Epinephrine 1:1000 Med Page"
            >EPINEPHRINE (1:1,000)</a
          >
          at <strong>(0.3-0.5) mg IM</strong>.
        </p>
        <h3 class="PARAMEDIC">Paramedic/PHRN</h3>
        <p>
          1. Continue <strong>EMR / EMT TREATMENT</strong>.<br /><br />

          2. Establish IV access.<br /><br />

          3. In patients with persistent respiratory distress despite the above
          treatment, consider
          <a
            href="../../../DrugMaterial/MagnesiumFolder/magnesium.html"
            class="working-link"
            title="Magnesium Sulfate Med Page"
            >MAGNESIUM SULFATE</a
          >
          <strong>2 grams IV</strong> in 50 mL NS or premix bag, infused over 10
          minutes<br /><br />

          4.
          <a
            href="../../../DrugMaterial/MethylprednisoloneFolder/Methylprednisolone.html"
            class="working-link"
            title="Methylprednisolone Med Page"
            >METHYLPREDNISOLONE</a
          >
          <strong>125 mg IV/IM/IO</strong> or
          <a
            href="../../../DrugMaterial/DexamethasoneFolder/dexamethasone.html"
            class="working-link"
            title="Dexamethasone Med Page"
            >DEXAMETHASONE</a
          >
          <strong>10 mg IV/IO/PO</strong>.<br /><br />

          5. Consider
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a>
          application.<br /><br />

          6. Assist ventilations with in-line nebulizer kit and BVM if
          necessary.<br /><br />

          7. Reassess need for
          <a href="#" class="placeholder-link" title="Page coming soon"
            >Orotracheal Intubation</a
          >
          if respiratory symptoms worsen or do not improve with treatment.<br /><br />

          8. If in <u>severe</u> distress with impending respiratory failure,
          consider
          <a
            href="../../../DrugMaterial/Epi1000Folder/epi1000.html"
            class="working-link"
            title="Epinephrine 1:1000 Med Page"
            >EPINEPHRINE (1:1,000)</a
          >
          at <strong>0.3-0.5 mg IM</strong>.<br /><br />

          9. Continue to monitor need for
          <a href="#" class="placeholder-link" title="Page coming soon"
            >Orotracheal Intubation</a
          >
          if respiratory symptoms worsen or do not improve with treatment. See
          <a
            href="../../General/AirwayManagementSources/AirwayManagement.html"
            class="working-link"
            title="Airway Management SOG"
            >AIRWAY MANAGEMENT</a
          >
          Protocol.
        </p>

        <p>
          <strong>PEARLS</strong><br /><br />

          • Pulse oximetry and end-tidal CO2 (EtCO2) should be routinely used as
          an adjunct to other forms of respiratory monitoring.<br /><br />

          <img
            src="waveform.png"
            alt="Bronchospasm on waveform capnography"
            style="
              display: block;
              margin-left: auto;
              margin-right: auto;
              max-width: 100%;
              height: auto;
              float: none;
              align-self: center;
              justify-self: center;
            "
          /><br /><br />

          • Beware of patients with a “silent chest” (absent breath sounds) as
          this may indicate severe bronchospasm and impending respiratory
          failure.<br /><br />

          • Remember that not all wheezing is caused by asthma and that not all
          asthmatics wheeze.<br /><br />
          <span class="Indention">
            - Patients with congestive heart failure may present with lung
            sounds that mimic asthma (“cardiac wheeze”) <br /><br />
          </span>

          • Consider cardiac etiology for shortness of breath and/or chest pain
          and refer to
          <a href="#" class="placeholder-link" title="Page coming soon"
            >CHEST PAIN</a
          >
          protocol.<br /><br />

          • In the asthmatic patient, pharmacologic intervention should take
          priority over
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a>
          and be given in line with
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a
          >.<br /><br />

          •
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a>
          should not be initiated on patients with a systolic BP &lt; 90mmHg.
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a>
          increases intrathoracic pres-sure and can decrease venous return to
          the heart (compromising the patient’s perfusion). Contact Medical
          Control and use
          <a href="#" class="placeholder-link" title="Page coming soon">CPAP</a>
          cautiously if the systolic BP is between 90-100 mmHg for the same
          reason.<br /><br />

          • Giving positive pressure in the setting of bronchoconstriction,
          either via a Blind Insertion Airway Device
          <a href="#" class="placeholder-link" title="Page coming soon"
            >(BIAD)</a
          >
          or intubation, increases the risk of air trapping which can lead to
          pneumothorax and cardiovascular collapse. These interventions should
          be reserved for situations of respiratory failure.
        </p>

        <table class="EndTable">
          <thead>
            <tr>
              <th><strong>KEY DOCUMENTATION ELEMENTS </strong></th>
              <th><strong>PERTINENT ASSESSMENT FINDINGS </strong></th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>
                • Reparatory rate<br /><br />
                • Oxygen saturation and EtCO2<br /><br />
                • Use of accessory muscles<br /><br />
                • Breath sounds<br /><br />
                • Air entry<br /><br />
                • Mental status<br /><br />
                • Color<br /><br />
                • Response to interventions
              </td>
              <td>
                • In the setting of severe bronchoconstriction, wheezing might
                not be heard. Patients with known asthma who complain of chest
                pain or shortness of breath should be empirically treated, even
                if wheezing is absent.
              </td>
            </tr>
          </tbody>
        </table>
        <table class="QMTable">
          <tr>
            <td><strong>QUALITY METRICS</strong><br /><br /></td>
          </tr>
          <tr>
            <td>
              • CPAP utilization<br /><br />

              • Utilization of continuous pulse oximetry and EtCO2
            </td>
          </tr>
        </table>
      </div>
    </div>
    <script src="https://code.jquery.com/jquery-3.7.1.min.js"></script>
    <script src="Asthma.js"></script>
  </body>
  <footer class="footer">
    <p>&copy; 2025 LukiSoft. All rights reserved.</p>
  </footer>
</html>
